- 专利标题: NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS
-
申请号: US16759262申请日: 2018-10-18
-
公开(公告)号: US20210317128A1公开(公告)日: 2021-10-14
- 发明人: Marcus KOPPITZ , Holger SIEBENEICHER , Nico BRÄUER , Elisabeth POOK , Andrea ROTGERI , Roland NEUHAUS , Oliver Martin FISCHER , Jens NAGEL , Adam James DAVENPORT , James Lindsay CARR , Robert James TOWNSEND , Nina CONNELLY URSINYOVA , Shelley Anne PARROTT
- 申请人: Bayer Aktiengesellschaft , Bayer Pharma Aktiengesellschaft
- 申请人地址: DE Leverkusen; DE Berlin
- 专利权人: Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- 当前专利权人: Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- 当前专利权人地址: DE Leverkusen; DE Berlin
- 优先权: EP17198769.6 20171027
- 国际申请: PCT/EP2018/078567 WO 20181018
- 主分类号: C07D487/14
- IPC分类号: C07D487/14
摘要:
The present invention covers substituted. Pyrazolo-pyrrolo-pyrimidine-dione (PPPD) compounds of general formula (I): in which R1, R2 and R3 are as defined herein, methods of preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of neurogenic diseases, as a sole agent or in combination with other active ingredients.
公开/授权文献
信息查询